SAN FRANCISCO--(BUSINESS WIRE)--June 23, 1998--For individual
investors interested in learning the latest about
biotechnology/medical technology companies and stocks, the place to be
is at Informed Investors Forums in San Francisco and San Diego on
Sunday, July 26, and Saturday, Aug. 1, respectively.
Highly regarded for bringing executives of public companies to
discuss their companies and industries with individual investors,
Informed Investors will have executives from more than 20 public
biotech/medical technology companies, plus five industry experts, on
hand to bring individual investors up to date on the industry at the
two forums.
"We are delighted to assemble such an outstanding array of
knowledge to pass along their expertise and insight to individual
investors," said Tim Quast, chief operating officer of
Sacramento-based Informed Investors. "Anyone interested in
biotechnology, medical technology and life/health sciences would find
our Forums worthwhile. Also, listening to tapes is an excellent
alternative for those who cannot attend."
On Sunday, July 26, eight companies and two prominent keynote
speakers highlight the Fifth San Francisco Bay Area Biotech Stocks
Forum at the Hyatt at Fisherman's Wharf. The Forum runs from 8:30-1
p.m. The cost is $25 prepaid, $40 at the door. Audio tapes
(five-cassette set) are available for $45 plus $3.95
shipping/handling.
The keynote speakers at the San Francisco Forum are David
Steinberg, biotechnology analyst for Volpe Brown & Whelan, and Kurt
von Emster, portfolio manager for the San Mateo-based Franklin
Biotechnology Discovery Fund (NASDAQ:FBDIX). They will offer their
current insight into the industry and biotech stocks.
Executives from the following companies will give analyst-style
presentations: Protein Design Labs (NASDAQ:PDLI), Sangstat Medical
(NASDAQ:SANG), Megabios (NASDAQ:MBIO), Sugen (NASDAQ:SUGN), Chiron
(NASDAQ:CHIR), Shaman Pharmaceuticals (NASDAQ:SHMN) and SunPharm
(NASDAQ:SUNP). The eighth presenting company is pending.
On Saturday, Aug. 1 at the Mission Valley Radisson in San Diego,
investors will be treated to a full day of biotech/medical technology
presentations, commentary and insight. It will be the largest
biotech/medical technology forum to date geared primarily to
individual investors. The cost for the full day is $40 prepaid, or $55
at the door (space available). The cost for the morning or afternoon
sessions alone is $25 prepaid, or $40 at the door (space available).
Audio tapes are available. For the complete set of all companies and
presenters (10 cassettes), the cost is $83.50 plus $5.95
shipping/handling. For either the morning or afternoon session (five
cassettes), the cost is $45 plus $3.95 shipping/handling.
The morning program (8:30 a.m. to 12:15 p.m.) is devoted to
biotechnology companies. Companies committed thus far to presenting
are: Alliance Pharmaceutical (NASDAQ:ALLP), La Jolla Pharmaceutical
(NASDAQ:LJPC), Cytel Corp. (NASDAQ:CYTL), Isis Pharmaceuticals
(NASDAQ:ISIP) and Genentech (NYSE:GNE). Three other companies are
pending. The keynote speaker concluding the morning session is James
McCamant, Editor of the Medical Technology Stock Letter
(www.bioinvest.com). McCamant is a leading authority on biotechnology
investing.
The afternoon session begins at 1:30 with a keynote address by
Michael Yellen, portfolio manager of the GT Global Health Care Funds.
The concluding speaker at 4:30 is Dr. Alex Arrow, Vice
President/Research at Wedbush Morgan Securities. Companies committed
to presenting are: Inhale Therapeutics (NASDAQ:INHL), Medical Science
Systems (NASDAQ:MSSI), Zevex International (AMEX:ZVX) and BioSource
International (NASDAQ:BIOI). Other companies will be announced
shortly.
Informed Investors is well established as an important source of
current information for biotech investors. At its recent Beltway
Biotech Stocks Forum June 6 in Bethesda, MD, companies that presented
included Integra LifeSciences (NASDAQ:IART), Boston Life Sciences
(NASDAQ:BLSI), EntreMed (NASDAQ:ENMD), Gene Logic (NASDAQ:GLGC), OSI
Pharmaceuticals (NASDAQ:OSIP), CytRx (NASDAQ:CYTR) and SunPharm. Also,
attendees heard from biotech experts Dr. Alex Arrow and Kris Jenner,
Ph.D., M.D., biopharma analyst at T. Rowe Price (NASDAQ:TROW). Audio
tapes are available of that Forum for $45 plus $3.95 S/H.
Since 1993, Informed Investors has featured scores of quality
companies and industry experts at its Forums. Informed Investors
represents individual investors who collectively hold an estimated $2
billion in investable assets.
CONTACT: Informed Investors, Inc.
Sean Finnigan, Steve Chanecka or Tim Quast,
916/448-8222 or 800/992-4683
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: BANKING BIOTECHNOLOGY MEDICINE
COMPUTERS/ELECTRONICS COMED TRADESHOW
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 1998, Business Wire
|
